220 related articles for article (PubMed ID: 28162974)
1. A UBE2O-AMPKα2 Axis that Promotes Tumor Initiation and Progression Offers Opportunities for Therapy.
Vila IK; Yao Y; Kim G; Xia W; Kim H; Kim SJ; Park MK; Hwang JP; González-Billalabeitia E; Hung MC; Song SJ; Song MS
Cancer Cell; 2017 Feb; 31(2):208-224. PubMed ID: 28162974
[TBL] [Abstract][Full Text] [Related]
2. UBE2O promotes hepatocellular carcinoma cell proliferation and invasion by regulating the AMPKα2/mTOR pathway.
Shi Z; Liu R; Lu Q; Zeng Z; Liu Y; Zhao J; Liu X; Li L; Huang H; Yao Y; Huang D; Xu Q
Int J Med Sci; 2021; 18(16):3749-3758. PubMed ID: 34790050
[TBL] [Abstract][Full Text] [Related]
3. A new duet in cancer biology: AMPK the typical and UBE2O the atypical.
Vila IK; Song SJ; Song MS
Mol Cell Oncol; 2017; 4(3):e1304846. PubMed ID: 28616582
[No Abstract] [Full Text] [Related]
4. UBE2O promotes the proliferation, EMT and stemness properties of breast cancer cells through the UBE2O/AMPKα2/mTORC1-MYC positive feedback loop.
Liu X; Ma F; Liu C; Zhu K; Li W; Xu Y; Li G; Niu Z; Liu J; Chen D; Li Z; Fu Y; Qian C
Cell Death Dis; 2020 Jan; 11(1):10. PubMed ID: 31907353
[TBL] [Abstract][Full Text] [Related]
5. Diverse roles of the E2/E3 hybrid enzyme UBE2O in the regulation of protein ubiquitination, cellular functions, and disease onset.
Ullah K; Zubia E; Narayan M; Yang J; Xu G
FEBS J; 2019 Jun; 286(11):2018-2034. PubMed ID: 30468556
[TBL] [Abstract][Full Text] [Related]
6. A muscle-specific UBE2O/AMPKα2 axis promotes insulin resistance and metabolic syndrome in obesity.
Vila IK; Park MK; Setijono SR; Yao Y; Kim H; Badin PM; Choi S; Narkar V; Choi SW; Chung J; Moro C; Song SJ; Song MS
JCI Insight; 2019 Jul; 4(13):. PubMed ID: 31292296
[TBL] [Abstract][Full Text] [Related]
7. UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance.
Huang Y; Yang X; Lu Y; Zhao Y; Meng R; Zhang S; Dong X; Xu S; Wu G
Cell Death Differ; 2021 Feb; 28(2):671-684. PubMed ID: 32901121
[TBL] [Abstract][Full Text] [Related]
8. UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitination.
Ma M; Zhang C; Cao R; Tang D; Sang X; Zou S; Wang X; Xu H; Liu G; Dai L; Tian Y; Gao X; Fu X
Oncogene; 2022 Nov; 41(48):5199-5213. PubMed ID: 36273042
[TBL] [Abstract][Full Text] [Related]
9. AMP-Activated Protein Kinase α2 in Neutrophils Regulates Vascular Repair via Hypoxia-Inducible Factor-1α and a Network of Proteins Affecting Metabolism and Apoptosis.
Abdel Malik R; Zippel N; Frömel T; Heidler J; Zukunft S; Walzog B; Ansari N; Pampaloni F; Wingert S; Rieger MA; Wittig I; Fisslthaler B; Fleming I
Circ Res; 2017 Jan; 120(1):99-109. PubMed ID: 27777247
[TBL] [Abstract][Full Text] [Related]
10. The ubiquitin-conjugating enzyme UBE2O modulates c-Maf stability and induces myeloma cell apoptosis.
Xu Y; Zhang Z; Li J; Tong J; Cao B; Taylor P; Tang X; Wu D; Moran MF; Zeng Y; Mao X
J Hematol Oncol; 2017 Jul; 10(1):132. PubMed ID: 28673317
[TBL] [Abstract][Full Text] [Related]
11. AMPKα2 Regulates Bladder Cancer Growth through SKP2-Mediated Degradation of p27.
Kopsiaftis S; Sullivan KL; Garg I; Taylor JA; Claffey KP
Mol Cancer Res; 2016 Dec; 14(12):1182-1194. PubMed ID: 27638620
[TBL] [Abstract][Full Text] [Related]
12. Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O.
Mashtalir N; Daou S; Barbour H; Sen NN; Gagnon J; Hammond-Martel I; Dar HH; Therrien M; Affar el B
Mol Cell; 2014 May; 54(3):392-406. PubMed ID: 24703950
[TBL] [Abstract][Full Text] [Related]
13. AMP-activated protein kinase negatively regulates FcεRI-mediated mast cell signaling and anaphylaxis in mice.
Hwang SL; Li X; Lu Y; Jin Y; Jeong YT; Kim YD; Lee IK; Taketomi Y; Sato H; Cho YS; Murakami M; Chang HW
J Allergy Clin Immunol; 2013 Sep; 132(3):729-736.e12. PubMed ID: 23587332
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of eEF2 and p70S6K by AMPKalpha2 in heart.
Demeulder B; Zarrinpashneh E; Ginion A; Viollet B; Hue L; Rider MH; Vanoverschelde JL; Beauloye C; Horman S; Bertrand L
Biochim Biophys Acta; 2013 Jun; 1832(6):780-90. PubMed ID: 23466593
[TBL] [Abstract][Full Text] [Related]
15. UBE2O reduces the effectiveness of interferon-α via degradation of IFIT3 in hepatocellular carcinoma.
Li H; Liu Y; Cheng C; Wu Y; Liang SH; Wu L; Wang H; Tu CY; Yao HH; Meng FZ; Zhang B; Wang W; Wang JB; Liu LX
Cell Death Dis; 2023 Dec; 14(12):854. PubMed ID: 38129382
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of CHOP (C/EBP Homologous Protein) by the AMP-Activated Protein Kinase Alpha 1 in Macrophages Promotes CHOP Degradation and Reduces Injury-Induced Neointimal Disruption In Vivo.
Dai X; Ding Y; Liu Z; Zhang W; Zou MH
Circ Res; 2016 Oct; 119(10):1089-1100. PubMed ID: 27650555
[TBL] [Abstract][Full Text] [Related]
17. Long Noncoding RNA HCG18 Promotes Malignant Phenotypes of Breast Cancer Cells
Liu X; Qiao K; Zhu K; Li X; Zhao C; Li J; Feng D; Fang Y; Wang P; Qian C; Qiao W
Front Cell Dev Biol; 2021; 9():675082. PubMed ID: 34976998
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of AMPKα2 Promotes Pulmonary Arterial Smooth Muscle Cells Proliferation via mTOR/Skp2/p27(Kip1) Signaling Pathway.
Ke R; Liu L; Zhu Y; Li S; Xie X; Li F; Song Y; Yang L; Gao L; Li M
Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27258250
[TBL] [Abstract][Full Text] [Related]
19. AMPKα2 knockout enhances tumour inflammation through exacerbated liver injury and energy deprivation-associated AMPKα1 activation.
Qiu S; Liu T; Piao C; Wang Y; Wang K; Zhou Y; Cai L; Zheng S; Lan F; Du J
J Cell Mol Med; 2019 Mar; 23(3):1687-1697. PubMed ID: 30636376
[TBL] [Abstract][Full Text] [Related]
20. AMP-dependent protein kinase alpha 2 isoform promotes hypoxia-induced VEGF expression in human glioblastoma.
Neurath KM; Keough MP; Mikkelsen T; Claffey KP
Glia; 2006 May; 53(7):733-43. PubMed ID: 16518831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
